Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4585104
Max Phase: Preclinical
Molecular Formula: C40H65NO5
Molecular Weight: 639.96
Molecule Type: Unknown
Associated Items:
ID: ALA4585104
Max Phase: Preclinical
Molecular Formula: C40H65NO5
Molecular Weight: 639.96
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@]5(C(=O)NCCCCCC(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C
Standard InChI: InChI=1S/C40H65NO5/c1-9-13-33(44)46-31-18-19-37(6)29(36(31,4)5)17-20-39(8)30(37)16-15-27-28-26-35(2,3)21-23-40(28,24-22-38(27,39)7)34(45)41-25-12-10-11-14-32(42)43/h15,28-31H,9-14,16-26H2,1-8H3,(H,41,45)(H,42,43)/t28-,29-,30+,31-,37-,38+,39+,40-/m0/s1
Standard InChI Key: UJUNQECUYWXYIL-HMXQJACTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 639.96 | Molecular Weight (Monoisotopic): 639.4863 | AlogP: 9.26 | #Rotatable Bonds: 10 |
Polar Surface Area: 92.70 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.15 | CX Basic pKa: 0.75 | CX LogP: 8.49 | CX LogD: 5.42 |
Aromatic Rings: 0 | Heavy Atoms: 46 | QED Weighted: 0.14 | Np Likeness Score: 2.25 |
1. Medina-O'Donnell M, Rivas F, Reyes-Zurita FJ, Cano-Muñoz M, Martinez A, Lupiañez JA, Parra A.. (2019) Oleanolic Acid Derivatives as Potential Inhibitors of HIV-1 Protease., 82 (10): [PMID:31617361] [10.1021/acs.jnatprod.9b00649] |
Source(1):